TRAP-2 study

The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2 overexpressing adenocarcinoma of the esophagus or gastroesophageal junction.

Meer over deze studie is te vinden op: TRAP-2 studie (Slokdarmkanker)